Vascular Therapies' COLL-R(tm) Demonstrates Potential to Improve AV Graft Patency in Hemodialysis Patients CRESSKILL, N.J., Nov. 12, 2008 (GLOBE NEWSWIRE) -- Vascular Therapies LLC, a combination product company, recently announced encouraging safety and efficacy data from the company's First-in-Man study...

Vascular Therapies LLC Appoints Samuel M. Liang as President and Chief Executive Officer CRESSKILL, N.J., July 22, 2008 (PRIME NEWSWIRE) -- Vascular Therapies LLC, a vascular combination device company, today announced that it has appointed Samuel M. Liang as President and Chief Executive...